Perelman School of Medicine at the University of Pennsylvania

Center for
Global Health

Center for Global Health

Andrew P. Steenhoff, MBBCh, DCH

Andrew P. Steenhoff, MBBCh, DCH
More Info

Scholar

  •  Medical Director, Global Health | Attending Physician, Division of Infectious Diseases at Children's Hospital | Associate Professor of Pediatrics, University of Pennsylvania
  •  Botswana | Dominican Republic | Cameroon | Ghana | South Africa
  •   Global Child Health' | HIV/AIDS | Partnerships | Pediatrics | Tuberculosis

Languages: English (native), Zulu (basic), French (basic), Afrikaans (basic)

Bio statement

Dr. Steenhoff trained at the Univ. of the Witwatersrand, Johannesburg. He completed pediatric residencies at Chris-Hani Baragwanath Hospital & Albert Einstein Medical Center, Philadelphia and Infectious Diseases Fellowship at Children’s Hospital of Philadelphia (CHOP). From 2007-2015 he served as Associate Country Director & Research Director, Botswana-UPenn Partnership. In 7/2015, he became Medical Director of CHOP’s Global Health Center. Andrew combines clinical, public health and research skills to improve child health in LMICs. His research focuses on pediatric ID with a particular interest in tuberculosis. He is an Associate Professor of Pediatrics, UPenn and Adjunct Senior Lecturer, University of Botswana.

Recent global health projects

1. “Clinical Standards for Drug-susceptible TB in Children and Adolescents” was recently published in the International Journal of TB and Lung Disease. This aims to provide guidance for the diagnosis, treatment, and management of drug-susceptible TB in children and adolescents around the world. Fifty-two global experts in pediatric TB participated in a Delphi consensus process. After eight rounds of revisions, 51/52 (98%) participants endorsed the final document. These consensus-based clinical standards, which should be adapted to local contexts, will improve the care of children and adolescents affected by TB globally.


2. Neonatal health in low- and middle-income countries - now is the time. The first 28 days after birth—the neonatal period—is the most vulnerable month for a child. This editorial team (Drs Nakstad, Ashish, Coffin and Steenhoff) was pleased to use this special issue of the Journal Frontiers as an opportunity to identify new frontiers in global neonatal health, especially in the context of two global crises—the SARS-CoV-2 pandemic and climate change. Of the 40 manuscripts in this Research Topic, first authors represented 15 countries; six in Africa (Botswana, Ethiopia, Nigeria, South Africa, Tanzania, Uganda), five in Asia (Bangladesh, China, India, Japan, Malaysia), three from Europe (Sweden, Switzerland, United Kingdom) and one in North America (United States). With an eye to the future, we hope that this collection will be part of a “publication shift” where many future research topics will be dedicated to neonatology in LMIC and that journals will increasingly focus on highlighting scholarship to advance neonatal care in LMIC.

Selected publications

  1. Chiang SS, Graham SM, Schaaf HS, Marais BJ, Sant'Anna CC, Sharma S, Starke JR, Triasih R, Achar J, Amanullah F, Armitage LY, Aurilio RB, Buck WC, Centis R, Chabala C, Cruz AT, Demers AM, du Preez K, Enimil A, Furin J, Garcia-Prats AJ, Gonzalez NE, Hoddinott G, Isaakidis P, Jaganath D, Kabra SK, Kampmann B, Kay A, Kitai I, Lopez-Varela E, Maleche-Obimbo E, Malaspina FM, Velásquez JN, Nuttall JJC, Oliwa JN, Andrade IO, Perez-Velez CM, Rabie H, Seddon JA, Sekadde MP, Shen A, Skrahina A, Soriano-Arandes A, Steenhoff AP, Tebruegge M, Tovar MA, Tsogt B, van der Zalm MM, Welch H, Migliori GB. Clinical standards for drug-susceptible TB in children and adolescents. Int J Tuberc Lung Dis. 2023 Aug 1;27(8):584-598. doi: 10.5588/ijtld.23.0085. PMID: 37491754; PMCID: PMC10365562.

  2. Linn AR, Dubois MM, Steenhoff AP. Under-Reporting of Tuberculosis Disease among Children and Adolescents in Low and Middle-Income Countries: A Systematic Review. Trop Med Infect Dis. 2023 May 31;8(6):300. doi: 10.3390/tropicalmed8060300. PMID: 37368718; PMCID: PMC10304505.

  3. Bauserman M, Crouse H, Steenhoff AP, Vinograd AM, Robison JA, Batra M, Cohn KA, Eckerle M; PEDIATRIC GLOBAL HEALTH FELLOWSHIP EDUCATORS GROUP. Strengthening Pediatric Global Health Fellowship Programs: Process Toward Accreditation. Pediatrics. 2023 Jul 1;152(1):e2023061283. doi: 10.1542/peds.2023-061283. PMID: 37288509.

  4. Steenhoff AP, Coffin SE, Kc A, Nakstad B. Editorial: Neonatal health in low- and middle-income countries. Now is the time. Front Pediatr. 2023 Apr 13;11:1168915. doi: 10.3389/fped.2023.1168915. PMID: 37124177; PMCID: PMC10133691.

  5. Kitt E, Hayes M, Ballester L, Sewawa KB, Mulale U, Mazhani L, Arscott-Mills T, Coffin SE, Steenhoff AP. Assessing antibiotic utilization among pediatric patients in Gaborone, Botswana. SAGE Open Med. 2022 Jun 20;10:20503121221104437. doi: 10.1177/20503121221104437. PMID: 36814934; PMCID: PMC9939905.

  6. Geoghegan S, Acosta F, Stephens LC, Gillan H, Valera S, Drew RJ, Eogan M, Ratner AJ, Steenhoff AP, Butler KM, Feemster KA. Maternity care provider acceptance of a future Group B Streptococcus vaccine - A qualitative study in three countries. Vaccine. 2023 Mar 17;41(12):2013-2021. doi: 10.1016/j.vaccine.2023.02.037. Epub 2023 Feb 18. PMID: 36803900.

  7. Richards SD, Hayes M, Mazhani L, Arscott-Mills T, Mulale U, Coffin S, Steenhoff AP, Kitt E. Severity of illness and mortality among children admitted to a tertiary referral hospital in Botswana: A secondary data analysis of a prospective cohort study. SAGE Open Med. 2023 Jan 29;11:20503121221149356. doi: 10.1177/20503121221149356. PMID: 36741934; PMCID: PMC9893097.

  8. Hanze Villavicencio KL, Job MJ, Burghard AC, Taffet A, Banda FM, Vurayai M, Mokomane M, Arscott-Mills T, Mazhani T, Nchingane S, Thomas B, Steenhoff AP, Ratner AJ. Genomic Analysis of Group B Streptococcus Carriage Isolates From Botswana Reveals Distinct Local Epidemiology and Identifies Novel Strains. Open Forum Infect Dis. 2023 Oct 3;10(10):ofad496. doi: 10.1093/ofid/ofad496. PMID: 37869411; PMCID: PMC10588617.

Last Updated: 08 November 2023